MDM2 309 polymorphism is associated with missed abortion

Human Reproduction

Volumn 24, Issue 6, 2009, Pages 1346-1349

  Fang, Yan ^a   Kong, Beihua ^a   Yang, Qifeng ^a   Ma, Daoxin ^a   Qu, Xun ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

MDM2; Missed abortion; Polymorphism; Pregnancy

Indexed keywords

PROTEIN MDM2;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MISSED ABORTION; PLACENTA VILLUS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

MURINAE;

EID: 66249099504     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dep044     Document Type: Article

References (30)

1. Arva NC, Gopen TR, Talbott KE, Campbell LE, Chicas A, White DE, Bond GL, Levine AJ, Bargonetti J. A chromatin-associated and transcriptionally inactive p53-MDM2 complex occurs in mdm2 SNP309 homozygous cells. J Biol Chem 2005;29:26776-26787.
2. Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Srva NC, Bargonetti J, Bartel F, Taubert H, Wuerl P et al. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 2004;119:591-602.
3. Brown DR, Thomas CA, Deb SP. The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis. EMBO J 1998;17:2513-2525.
4. Carvajal D, Tovar C, Yang H, Vu BT, Heimbrook DC, Vassilev LT. Activation of p53 by MDM2 antagonists can protect proliferating cells from mitotic inhibitors. Cancer Res 2005;65:1918-1924.
5. Choi HK, Choi BC, Lee SH, Kin JW, Cha KY, Baek KH. Expression of angiogenesis- and apoptosis-related genes in chorionic villi derived from recurrent pregnancy loss patients. Mol Reprod Dev 2003;1:24-31.
6. Clifford K, Rai R, Watson H, Regan L. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod 1994;9:1328-1332.
7. Dubs-Poterszman MC, Tocque B, Wasylyk B. MDM2 transformation in the absence of p53 and abrogation of the p 107 G1 cell-cycle arrest. Oncogene 1995;11:2445-2449.
8. Fakharzadeh SS, Trusko SP, George DL. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J 1991;10:1565-1569.
9. Griebel CP, Halvorsen J, Golemon TB, Day AA. Management of spontaneous abortion. Am Fam Physician 2005;72:1243-1250.
10. Halperine R, Peller S, Rotschild M, Bukvsky I, Schneider D. Placental apoptosis in normal and abnormal pregnancies. Gynecol Obstet Invest 2000;50:84-87.
11. Hatasaka HH. Recurrent miscarriage: epidemiologic factors, definitions, and incidence. Clin Obstet Gynecol 1994;37:625-634.
12. Hong Y, Miao X, Zhang X, Ding F, Luo A, Guo Y, Tan W, Liu Z, Lin D. The role of p53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma. Cancer Res 2005;65:9582-9587.
13. Jerzak M, Bischof P. Apoptosis in the first trimester human placenta: the role in maintaining immune privilege at the maternal-foetal interface and in the trophoblast remodeling. Eur J Obstet Gynecol Reprod Biol 2002;100:138-142.
14. Jones SN, Hancock AR, Vogel H, Donehower LA, Bradley A. Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis. Proc Natl Acad Sci USA 1998;95: 15608-15612.
15. LaRusch GA, Jackson MW, Dunbar JD, Warren RS, Donner DB, Mayo LD. Nutlin3 blocks vascular endothelial growth factor induction by preventing the interaction between hypoxia inducible factor 1 a and Hdm2. Cancer Res 2007;67:450-454.
16. Levy R, Nelson DM. To be, or not to be, that is the question. Apoptosis in human trophoblast. Placenta 2000;21:1-13.
17. Ohmiya N, Taguchi A, Mabuchi N, Itoh A, Hirooka Y, Niwa Y, Goto H. MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis. J Clin Oncol 2006;24:4434- 4440.
18. Pietrowski D, Tempfer C, Bettendorf H, Burkle B, Nagele F, Unfried G, Keck C. Angiopoietin-2 polymorphism in women with idiopathic recurrent miscarriage. Fertil Steril 2003;4:1026-1029.
19. Pietrowski D, Bettendorf H, Riener EK, Keck C, Hefler LA, Huber JC, Tempfer C. Recurrent pregnancy failure is associated with a polymorphism in the p53 tumor suppressor gene. Hum Reprod 2005; 4:848-851.
20. Quenby S, Brazeau C, Drakeley A, Lewis-Jones DI, Vince G. Oncogene and tumour suppressor gene products during trophoblast differentiation in the first trimester. Mol Hum Reprod 1998;4:477-481.
21. Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, Zeng Q, Dillehay LE, Madan A, Semenza GL, Bedi A. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1 alpha. Genes Dev 2000;14:34-44.
22. Ries S, Biederer C, Woods D, Shifman O, Shirasawa S, Sasa-zuki T, McMahon M, McCormick F. Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p 19ARF. Cell 2000;103:321-330.
23. Savion S, Lepsky E, Orenstein H, Carp H, Shepshelovich J, Torchinsky A, Fein A, Toder V. Apoptosis in the uterus of mice with pregnancy loss. Am J Reprod Immunol 2002;47:118-127.
24. Sivaraman L, Conneely OM, Medina D, O'Malley BW. p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis. Proc Natl Acad Sci USA 2001;98:12379-12384.
25. Toledo F, Wahl GM. MDM2 and MDM4: p53 regulators as targets in anticancer therapy. Int J Biochem Cell Biol 2007;39:1476-1482.
26. Ueno M, Katayama K, Nakayama H, Doi K. Mechanisms of 5-azacytidine (5Azc)-induced toxicity in the rat foetal brain. Int J Exp Pathol 2002; 83:139-150.
27. Warburton D, Fraser FC. Spontaneous abortion risks in man: data from reproductive histories collected in a medical genetics unit. Am J Hum Genet 1964;16:1-25.
28. Wu X, Bayle JH, Olson D, Levine AJ. The p53-mdm2-2 autoregulatory feedback loop. Genes Dev 1993;7:1126-1132.
29. Yuan H, Xiaoping M, Xuemei ZH, Fang D, Aiping L, Yongli G, Wen T, Zhihua L, Dongxin L. The role of p53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma. Cancer Res 2005; 65:9582-9587.
30. Zauberman A, Flusberg D, Haupt Y, Barak Y, Oren M. A functional p53-responsive intronic promoter is contained within the human mdm2 gene. Nucleic Acids Res 1995;23:2584-2592.